Background illustration for clinical trials search

Paid Clinical Trials Madison

Discover 520 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for
Acute Myeloid Leukemia
Location: Madison WI, Milwaukee WI, Park Ridge IL, Maywood IL,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT04293562

Phase 3, Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Madison WI, Milwaukee WI, DeKalb IL, Grayslake IL,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase 3, Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

for
Ovarian Cancer, Cholangiocarcinoma Recurrent,
Location: Madison WI, Philadelphia PA, Houston TX, Tampa FL
Sponsor: Verismo Therapeutics

Sex: All

Age: 18+

Code: NCT05568680

Phase 1, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: Madison WI, Oconomowoc WI, Summit WI, Rockford IL,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase 3, Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Breast Cancer,
Location: Madison WI, Indianapolis IN, St Louis MO,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06625775

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Prospective Sub-Study of the Global Hypophosphatasia Registry

for
Hypophosphatasia
Location: Madison WI, Chicago IL, Kansas City MO, Columbus OH,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 0+

Code: NCT05234567

Recruiting

A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)

for
Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Location: Madison WI, Indianapolis IN, St Louis MO, Cincinnati OH,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 40 - 55

Code: NCT07636811

Phase 2, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Madison WI, Elmhurst IL, Chicago IL, Minneapolis MN,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase 3, Recruiting

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for
Endometrial Cancer, Gastric Cancer,
Location: Madison WI, Grand Rapids MI, Cincinnati OH, Columbus OH,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05489211

Phase 2, Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for
Endometrial Cancer
Location: Madison WI, Arlington Heights IL, Evanston IL,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase 3, Recruiting

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

for
Cytomegalovirus Infections, Kidney Transplant Infection,
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT06407232

Phase 3, Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Madison WI, Milwaukee WI, Maywood IL, Chicago IL,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Madison WI, Milwaukee WI, Maywood IL, Chicago IL,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

for
Lung Transplant; Complications,
Location: Madison WI, Minneapolis MN, Ann Arbor MI, Nashville TN,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06399302

Recruiting

Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients

for
Acute Kidney Injury, Biomarkers
Location: Madison WI, Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT05988658

Recruiting

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

for
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute,
Location: Madison WI, Chicago IL, Columbus OH, Nashville TN,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06501196

Phase 1, Recruiting

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Madison WI, Chicago IL, Rochester MN, Grand Rapids MI,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06742996

Phase 3, Recruiting

CAR-T Long Term Follow Up (LTFU) Study

for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Madison WI, Chicago IL, Ann Arbor MI, Detroit MI,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0 - 70+

Code: NCT02445222

Phase 3, Recruiting

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

for
B-cell Malignancy, Relapsed Cancer, Refractory Cancer,
Location: Madison WI, Milwaukee WI, Rochester MN, St Louis MO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06634589

Phase 1, Phase 2, Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG,
Location: Madison WI, Chicago IL, Greenwood IN, Gahanna OH,
Sponsor: Theralase® Technologies Inc.

Sex: All

Age: 18+

Code: NCT03945162

Phase 2, Recruiting